Breast Cancer Biology

The aim of our laboratory is to understand the molecular pathology of breast cancer to identify new therapeutic targets. We are evaluating the therapeutic potential of targeting enzymes mediating post-translational modifications that are overexpressed/activated in breast cancer compared to normal breast tissues. We are currently focusing on the family of protein arginine methyltransferases (PRMTs).